Penserra Capital Management LLC Repligen Corp Transaction History

Penserra Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$247.59 - $304.47 $6.93 Million - $8.52 Million	-27,989 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$194.77 - $324.21 $5.45 Million - $9.07 Million	27,989 New	27,989 $8.09 Million
Q2 2021 Aug 12, 2021	SELL	$165.87 - $220.95 $4.01 Million - $5.34 Million	-24,163 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$180.37 - $226.26 $2.32 Million - $2.9 Million	-12,835 Reduced 34.69%	24,163 $4.7 Million
Q4 2020 Feb 12, 2021	BUY	$148.08 - $206.57 $5.48 Million - $7.64 Million	36,998 New	36,998 $7.09 Million
Q2 2020 Aug 14, 2020	SELL	$94.33 - $140.48 $41,033 - $61,108	-435 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$84.96 - $109.14 $13,508 - $17,353	159 Added 57.61%	435 $53,000
Q4 2019 Feb 14, 2020	BUY	$73.84 - $93.08 $20,379 - $25,690	276 New	276 $28,000
Q3 2019 Nov 15, 2019	SELL	$76.65 - $95.51 $8.47 Million - $10.6 Million	-110,565 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$54.2 - $85.95 $5.99 Million - $9.5 Million	110,565 New	110,565 $9.5 Million

485

54.1M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $9.21B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.